Blair William & CO Amgen Inc Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

A detailed history of Blair William & CO transactions in Amgen Inc stock. As of the latest transaction made, Blair William & CO holds 200,305 shares of AMGN stock, worth $59 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

200,305

Previous 187,658 6.74%

Holding current value

$59 Million

Previous $58.6 Million 10.07%

% of portfolio

0.19%

Previous 0.18%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $3.91 Million - $4.27 Million	12,647 Added 6.74%	200,305 $64.5 Million
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $13.7 Million - $16.6 Million	51,957 Added 38.29%	187,658 $58.6 Million
Q1 2024 May 09, 2024	BUY	$268.87 - $324.56 $5.91 Million - $7.13 Million	21,970 Added 19.32%	135,701 $38.6 Million
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $273,854 - $308,940	-1,071 Reduced 0.93%	113,731 $32.8 Million
Q3 2023 Nov 09, 2023	BUY	$218.65 - $271.46 $2.47 Million - $3.07 Million	11,296 Added 10.91%	114,802 $30.9 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $609,598 - $720,837	-2,845 Reduced 2.68%	103,506 $23 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $156,246 - $190,438	-692 Reduced 0.65%	106,351 $25.7 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $458,060 - $582,020	-2,000 Reduced 1.83%	107,043 $28.1 Million
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $851,376 - $960,197	3,793 Added 3.6%	109,043 $24.6 Million
Q2 2022 Aug 10, 2022	SELL	$230.71 - $256.74 $484,721 - $539,410	-2,101 Reduced 1.96%	105,250 $25.6 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $116,213 - $128,562	-530 Reduced 0.49%	107,351 $26 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $5.48 Million - $6.28 Million	27,573 Added 34.33%	107,881 $24.3 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $1.05 Million - $1.23 Million	4,963 Added 6.59%	80,308 $17.1 Million
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $1.06 Million - $1.18 Million	-4,548 Reduced 5.69%	75,345 $18.4 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $6.83 Million - $7.96 Million	-30,763 Reduced 27.8%	79,893 $19.9 Million
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $1.66 Million - $1.97 Million	7,651 Added 7.43%	110,656 $25.4 Million
Q3 2020 Nov 06, 2020	SELL	$234.65 - $260.95 $2.01 Million - $2.24 Million	-8,580 Reduced 7.69%	103,005 $26.2 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $663,652 - $814,392	3,355 Added 3.1%	111,585 $26.3 Million
Q1 2020 May 11, 2020	SELL	$182.24 - $241.7 $428,264 - $567,995	-2,350 Reduced 2.13%	108,230 $21.9 Million
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $945,103 - $1.21 Million	4,995 Added 4.73%	110,580 $26.7 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $1.06 Million - $1.26 Million	-6,062 Reduced 5.43%	105,585 $20.4 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $1.36 Million - $1.6 Million	8,185 Added 7.91%	111,647 $20.6 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $1.27 Million - $1.44 Million	-7,043 Reduced 6.37%	103,462 $19.7 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $1.35 Million - $1.58 Million	7,577 Added 7.36%	110,505 $21.5 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $2.27 Million - $2.56 Million	12,262 Added 13.52%	102,928 $21.3 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $205,237 - $230,526	-1,236 Reduced 1.34%	90,666 $16.7 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $859,857 - $1 Million	-5,075 Reduced 5.23%	91,902 $15.7 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $1.04 Million - $1.17 Million	6,183 Added 6.81%	96,977 $16.9 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $15.2 Million - $17.3 Million	90,794	90,794 $16.9 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account